TRPM8 and prostate carcinoma: There is contradictory information about the effect of TRPM8 modulation in prostate cancer, as both agonists and antagonists have been shown to decrease proliferation and migration and promote apoptosis in PCa cells in vitro (Grolez and Gkika, 2016).